Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes?
George
James N
JN
D000368:Aged; D001327:Autoimmune Diseases / Q000145:classification; D001853:Bone Marrow / Q000473:pathology; D002999:Clone Cells / Q000473:pathology; D003937:Diagnosis, Differential; D018450:Disease Progression; D004303:Dosage Compensation, Genetic; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D009503:Neutropenia / Q000209:etiology; D009504:Neutrophils / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D013577:Syndrome
D007166:Immunosuppressive Agents; D011241:Prednisone